# Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair

> **NCT01144039** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 27 (actual)

## Conditions studied

- Hypertrophy, Left Ventricular
- Aortic Stenosis
- Myocardial Ischemia
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** LG-group
- **DRUG:** HG-group
- **DRUG:** Placebo-group

## Key facts

- **NCT ID:** NCT01144039
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-11
- **Final completion:** 2008-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144039, "Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01144039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*